Get started
Author

YOHEI CHIBA

Observed name: Yohei Chiba
Observed institution: Iwate Medical University
ORCID: 0000-0002-0589-2285
Observed ORCID: 0000-0002-0589-2285
OpenAlex ID: A5070776271
Efficacy and Safety of Platinum-based Chemotherapy With Bevacizumab Followed by Bevacizumab Maintenance for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer During PARP Inhibitor Therapy: A Multicenter Retrospective Study
2023 · MARINA ABE, TADAHIRO SHOJI, et al. · Anticancer Research · 9
PDF
Efficacy of Platinum-based Chemotherapy for Platinum-sensitive Recurrent Ovarian Cancer During PARP Inhibitor Treatment: A Multicenter Retrospective Study
2025 · ERIKO TAKATORI, TADAHIRO SHOJI, et al. · Anticancer Research · 2
Efficacy and safety of bevacizumab-combined single-agent chemotherapy for platinum-resistant ovarian cancer that recurred during PARP inhibitor treatment
2026 · Eriko Takatori, Tadahiro Shoji, et al. · International Journal of Clinical Oncology · 1
Clinical outcomes of 5-day administration of topotecan combined with bevacizumab for platinum-resistant ovarian cancer: a multicenter retrospective analysis
2026 · Eriko Takatori, Tadahiro Shoji, et al. · International Journal of Clinical Oncology
Benefits of PARP inhibitor rechallenge in patients with platinum-sensitive recurrent ovarian cancer previously treated with a PARP inhibitor: a multicenter retrospective study
2026 · Ami Jo, Tadahiro Shoji, et al. · International Journal of Clinical Oncology
Impact of a Weekend-Off Lenvatinib Dosing Regimen on Dose Intensity and Safety in Lenvatinib–Pembrolizumab Therapy for Advanced Endometrial Cancer
2026 · Nanako Jonai, Masahiro Kagabu, et al. · Research Square
PDF
Safety and oncologic outcomes of total laparoscopic versus abdominal hysterectomy following diagnostic conization for adenocarcinoma in situ and stage IA1 cervical cancer: a multicenter retrospective study
2026 · Yoshitaka Kaido, Masahiro Kagabu, et al. · International Journal of Clinical Oncology
PDF
Peripheral blood lymphocyte and eosinophil dynamics with chemotherapy and pembrolizumab in cervical cancer
2026 · Sho Sato, Masahiro Kagabu, et al. · International Journal of Clinical Oncology
Works count: 8
Citation count: 12
H-index: 2
I10-index:
Year
Topic
Type